These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24713888)

  • 1. Simultaneous measurement of thirteen steroid hormones in women with polycystic ovary syndrome and control women using liquid chromatography-tandem mass spectrometry.
    Keefe CC; Goldman MM; Zhang K; Clarke N; Reitz RE; Welt CK
    PLoS One; 2014; 9(4):e93805. PubMed ID: 24713888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid metabolome profiling of follicular fluid in normo- and hyperandrogenic women with polycystic ovary syndrome.
    Yang Z; Zhou W; Zhou C; Zhou Y; Liu X; Ding G; Hu Y; Pan J; Sheng J; Jin L; Huang H
    J Steroid Biochem Mol Biol; 2021 Feb; 206():105806. PubMed ID: 33340681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Steroid hormone analysis of adolescents and young women with polycystic ovarian syndrome and adrenocortical dysfunction using UPC
    Swart AC; du Toit T; Gourgari E; Kidd M; Keil M; Faucz FR; Stratakis CA
    Pediatr Res; 2021 Jan; 89(1):118-126. PubMed ID: 32247282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of selected androgens using liquid chromatography-tandem mass spectrometry in reproductive-age women with Type 1 diabetes.
    Gunness A; Pazderska A; Ahmed M; McGowan A; Phelan N; Boran G; Taylor AE; O'Reilly MW; Arlt W; Moore K; Behan LA; Sherlock M; Gibney J
    Hum Reprod; 2018 Sep; 33(9):1727-1734. PubMed ID: 30020477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity and predictive value of circulating testosterone assessed by tandem mass spectrometry for the diagnosis of polycystic ovary syndrome by the National Institutes of Health 1990 criteria.
    Salameh WA; Redor-Goldman MM; Clarke NJ; Mathur R; Azziz R; Reitz RE
    Fertil Steril; 2014 Apr; 101(4):1135-1141.e2. PubMed ID: 24534279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Androgen and 17-hydroxyprogesterone concentrations in blood serum versus menstrual patterns in women with polycystic ovary syndrome (PCOS)].
    Rudnicka E; Kunicki M; Radowicki S
    Ginekol Pol; 2010 Oct; 81(10):745-9. PubMed ID: 21117302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of androgen concentration in women: liquid chromatography-tandem mass spectrometry and extraction RIA show comparable results.
    Janse F; Eijkemans MJ; Goverde AJ; Lentjes EG; Hoek A; Lambalk CB; Hickey TE; Fauser BC; Norman RJ
    Eur J Endocrinol; 2011 Dec; 165(6):925-33. PubMed ID: 21969522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
    Handelsman DJ; Teede HJ; Desai R; Norman RJ; Moran LJ
    Hum Reprod; 2017 Feb; 32(2):418-422. PubMed ID: 27999117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining hyperandrogenism in polycystic ovary syndrome: measurement of testosterone and androstenedione by liquid chromatography-tandem mass spectrometry and analysis by receiver operator characteristic plots.
    Barth JH; Field HP; Yasmin E; Balen AH
    Eur J Endocrinol; 2010 Mar; 162(3):611-5. PubMed ID: 20008514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The serum steroid signature of PCOS hints at the involvement of novel pathways for excess androgen biosynthesis.
    Altinkilic EM; du Toit T; Sakin Ö; Attar R; Groessl M; Flück CE
    J Steroid Biochem Mol Biol; 2023 Oct; 233():106366. PubMed ID: 37499841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous quantitation of four androgens and 17-hydroxyprogesterone in polycystic ovarian syndrome patients by LC-MS/MS.
    Cao Z; Lu Y; Cong Y; Liu Y; Li Y; Wang H; Zhang Q; Huang W; Liu J; Dong Y; Tang G; Luo YR; Yin C; Zhai Y
    J Clin Lab Anal; 2020 Dec; 34(12):e23539. PubMed ID: 32820576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of urinary androgens in women with polycystic ovary syndrome using LC-QqQ/MS and the application of thin film solid-phase microextraction (TF-SPME).
    Rajska A; Raczak-Gutknecht J; Struck-Lewicka W; Buszewska-Forajta M; Wityk P; Verding P; Kowalewska A; Siluk D; Rachoń D; Jan Markuszewski M
    J Chromatogr A; 2024 Mar; 1718():464735. PubMed ID: 38364619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid Hormone Profiling in Hyperandrogenism and Non-hyperandrogenism Women with Polycystic Ovary Syndrome.
    Ge J; Yang N; Zhang X; Li M; Zhang W; He J; Zhu H; Cheng X; Shen S; Ge W
    Reprod Sci; 2022 Dec; 29(12):3449-3458. PubMed ID: 35835901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent Associations Between Serum Androgens and Ovarian Reserve Markers Revealed in Patients With Polycystic Ovary Syndrome.
    Li Y; Zhai Y; Li L; Lu Y; Su S; Liu Y; Xu Z; Xin M; Zhang Q; Cao Z
    Front Endocrinol (Lausanne); 2022; 13():881740. PubMed ID: 35757414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C; Reyna R; Boots LS; Azziz R
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total testosterone to dihydrotestosterone ratio assessed by LC-MS/MS predicts a worse metabolic profile not only in PCOS patients.
    Ambroziak U; Kuryłowicz A; Kępczyńska-Nyk A; Bartoszewicz Z; Kondracka A; Jaźwiec R; Samborowska E; Dadlez M; Wysłouch-Cieszyńska A; Bednarczuk T
    Ginekol Pol; 2017; 88(1):5-8. PubMed ID: 28157253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.